BackCERo Therapeutics Holdings - Warrants (13/02/2029) Overview
CERo Therapeutics Holdings Inc. - Warrants (13/02/2029)

CERo Therapeutics Holdings - Warrants (13/02/2029) Return on Equity

Latest ROE for CERo Therapeutics Holdings - Warrants (13/02/2029): 11.12% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

1111.99%

Return on Equity

1111.99%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

CERo Therapeutics Holdings - Warrants (13/02/2029) (CEROW) FAQ

As of the most recent data, CEROW shows a ROE of 11.12%. That is above the sector sector average of -4.03%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about -4.03%. CERo Therapeutics Holdings - Warrants (13/02/2029) is at 11.12%, which is higher that average. That is roughly 27727.0% above the sector mean. Use the comparison chart on this page to see how CEROW stacks up against individual peers as well.

Check the historical chart to see whether CEROW's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare CERo Therapeutics Holdings - Warrants (13/02/2029) with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has CERo Therapeutics Holdings - Warrants (13/02/2029)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 11.12%) with ownership activity and broader fundamentals.